EMTT is short of Extracorporeal Magnetotransduction Therapy. It is a form of magnetic therapy that opens doors to a world of possibilities in regeneration and rehabilitation. This therapy allows physicians to broaden their scope of treatments for patients with musculoskeletal conditions and tendinopathies.
Called a “transformational technology,” EMTT helps patients get better faster without unnecessary risk, without surgery, and without downtime.
EMTT was first introduced to the United States in 2019 by The Institute for Tissue Generation and Repair. Dr. John Knab provides insight into this treatment in a full interview with CuraMedix:
Q and A with Dr. John Knab
Q: When did you first learn about EMTT?
“I was fortunate to participate in a webinar sponsored by CuraMedix featuring Prof. Dr. Ludger Gerdesmeyer last year. I was fascinated, did my homework, and was sold on the idea and committed to bringing this technology into my practice-even before the FDA’s final clearance.”
Q: How long have you been using your EMTT device?
“In just two years, we’re already at 10.5 million impulses and have treated close to 700 patients.”
Q: Where has EMTT shown the most success and promise for you and your patients?
“I’m looking forward to seeing how effective EMTT is for my spine patients. Particularly those with painful vertebral body endplate edema. This is a notoriously difficult condition to treat, and if EMTT has even a small effect on these hard-to-reach lesions, it would definitely be a game changer for my practice. I am seeing some initial promise in terms of treatment of chronically painful and tight iliacus muscle pathology. For me, the distal iliacus is a tough muscle to treat with injections, but EMTT gets right in there.”
CLICK HERE to read the full interview and get more information about this new state-of-the-art treatment.
Fill out the form below to get started.